Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Exchange Rate Effect (2016 - 2025)

Protalix BioTherapeutics (PLX) has 16 years of Exchange Rate Effect data on record, last reported at -$12000.0 in Q3 2025.

  • For Q3 2025, Exchange Rate Effect fell 500.0% year-over-year to -$12000.0; the TTM value through Sep 2025 reached $38000.0, up 167.86%, while the annual FY2024 figure was $25000.0, 121.93% up from the prior year.
  • Exchange Rate Effect reached -$12000.0 in Q3 2025 per PLX's latest filing, down from $4000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $54000.0 in Q4 2024 and bottomed at -$42000.0 in Q1 2023.
  • Average Exchange Rate Effect over 5 years is -$9777.8, with a median of -$10000.0 recorded in 2022.
  • Peak YoY movement for Exchange Rate Effect: crashed 900.0% in 2022, then skyrocketed 300.0% in 2024.
  • A 5-year view of Exchange Rate Effect shows it stood at $40000.0 in 2021, then crashed by 165.0% to -$26000.0 in 2022, then fell by 3.85% to -$27000.0 in 2023, then surged by 300.0% to $54000.0 in 2024, then crashed by 122.22% to -$12000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$12000.0 in Q3 2025, $4000.0 in Q2 2025, and -$8000.0 in Q1 2025.